Imaging News

In a study of patients with COVID-19 who underwent cardiac MRI, among the signs of cardiac involvement in COVID-19 were cardiac symptoms, ECG abnormalities and cardiac biomarker elevations.

Employing intravascular lithotripsy facilitated transcatheter mitral valve replacement in a patient with severe mitral annular and mitral valve leaflet calcification, according to a report on a first-in-human procedure.

In two prospective cohort studies and a meta-analysis of present and past studies, elevated LDL triglycerides were associated with increased risk for atherosclerotic CVD and its components, researchers reported.

Healio and Cardiology Today have curated a list of the top cardiology and cardiac/vascular intervention news reported from meetings in 2022.

Healio and Cardiology Today have compiled a list of the most-read headlines of December 2022 in cardiology.

The American Heart Association Scientific Sessions were held Nov. 5 to 7 in Chicago, the first time they were conducted in-person since 2019.

Even in the COVID-19 era, atherosclerotic CVD remains the leading cause of death worldwide.

The American College of Cardiology announced the late-breaking science lineup for its Scientific Session to be held March 4-6, 2023 in New Orleans and online.

Ultromics announced its artificial intelligence-guided device for the diagnosis of HF with preserved ejection fraction via echocardiogram has received full marketing authorization from the FDA.

A deep-learning model using information from a single chest X-ray reliably predicted atherosclerotic CVD risk and statin eligibility when compared with a common risk calculator, researchers reported.